GlassScriptPhysician profile
Justin D Saliman
NPI 1346250107
$911,828.82
in general payments reported to CMS, 2019-2025
8 companies · $549 in 2025
The $549 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $193K · 2021: $108K · 2022: $275K · 2023: $128K · 2024: $159K · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $287K · Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $287,341.32 |
| Food and Beverage | $741.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $906,856.92 | 2019-2025 | Novostitch, Intellio Link Werewolf, Coblation |
| Intravu INC. | $4,400.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $156.14 | 2024-2025 | Aperfix Femoral Implant, Activbraid, Tapestry |
| Miach Orthopaedics, INC. | $143.88 | 2025 | |
| Innovation Technologies INC | $120.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $63.25 | 2025 | |
| Moximed, INC | $51.29 | 2024-2025 | Misha Knee System, Small, Left |
| Linvatec Corporation | $37.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$7.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Saliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.